Minnesota SF4940 mandates health plans to cover medical services and FDA-approved medications for dementia treatment.

Minnesota SF4940 requires health plan companies to cover all types of medical services and FDA-approved prescription medications for treating or slowing dementia progression. It also mandates coverage for diagnostic tests to determine the appropriateness or effectiveness of these treatments. The bill modifies step therapy requirements and outlines specific conditions for prior authorization, including automatic approval for certain drugs and streamlined forms for patients using enteral tubes. This legislation is set to take effect on January 1, 2027.

Minnesota SF4940 mandates health plans to cover medical services and FDA-approved medications for dementia treatment.

Minnesota SF4940 requires health plan companies to cover all types of medical services and FDA-approved prescription medications for treating or slowing dementia progression. It also mandates coverage for diagnostic tests to determine the appropriateness or effectiveness of these treatments. The bill modifies step therapy requirements and outlines specific conditions for prior authorization, including automatic approval for certain drugs and streamlined forms for patients using enteral tubes. This legislation is set to take effect on January 1, 2027.